March 28, 2026 11:43 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Modi says govt taking steps to shield Indians from impact of Middle East crisis | Bengal polls a ‘fight for liberation from fear’, says Amit Shah as he unveils TMC chargesheet | ‘Won’t mix politics with sport’: Bangladesh lifts IPL broadcast ban | ‘Feeling blessed’: PM Modi attends Surya Tilak ceremony at Ayodhya Ram Temple virtually | ‘No lockdown’: Union Minister Hardeep Singh Puri dismisses rumours, assures preparedness amid West Asia tensions | Middle East crisis: Govt cuts excise duty by Rs 10 on petrol and diesel, giving big relief amid global oil shock | ‘Big boost for NCR connectivity’: PM Modi to inaugurate Noida International Airport Phase 1 tomorrow | HDFC chairman Atanu Chakraborty resigned over power struggle with CEO Sashidhar Jagdishan: Report | PM Modi to chair meeting with CMs tomorrow amid West Asia conflict | ‘I said, no thanks’: Trump claims Iran offered him Supreme Leader role

FIR against Snapdeal CEO for selling prescription drugs online

| | May 01, 2015, at 11:58 pm
Mumbai, May 1 (IBNS) Maharashtra's Food and Drugs Administration (FDA) has ordered that a First Information Report (FIR) be filed against Kunal Bahl, the CEO of e-commerce giant Snapdeal.com, for the sale of prescription drugs online.
FDA commissioner Harshadeep Kamble said on Friday said the FIR has been ordered against  Bahl and directors of the company.
 
The FDA said it had received information about the alleged sale of a cough syrup, and certain tablets, both prescription drugs that can be sold only when prescribed by medical practitioner.
 
The FDA had issued a notice to the company asking it to delist the drugs and also furnish details of the drugs it offered for sale on the portal Snapdeal.com.
 
In a statement on Friday, Snapdeal said they are assisting in the probe and have delisted the products.
 
"In this matter, we are assisting the FDA team in this investigation and we will continue to do so. We have already delisted the products and said sellers and also stopped payment, in addition to providing all information to the FDA team as required by them," the statement said.
 
The FDA has said it is also checking to see if other e-retailers have sold drugs online.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.